thenewsfacts.com
  • Home
  • Latest News
  • Trending News
  • Technology
  • entertainment
  • Sports
  • Business
thenewsfacts.comthenewsfacts.com
Search
  • Home
  • Latest News
  • Trending News
  • Technology
  • entertainment
  • Sports
  • Business
Follow US
© thenewsfacts : All Rights Reserved.

COVID Vaccines

Covaxin BHU Study
COVID VaccinesLatest News

Covaxin BHU Study: BB Points Flaws in Data Points, Backs Strong Safety Track Record

By
NewsFacts Bureau

COVAXIN production to be demand-driven, says Bharat Biotech

By
TheNewsFacts

iNCOVACC: Bharat Biotech Reveals World’s 1st Nasal COVID Vaccine Price

By
TheNewsFacts

Bharat Biotech iNCOVACC Vaccine priced ₹800 in CoWIN, ₹325 for the Govt Supplies, Rollout in January 2023

By
TheNewsFacts
Teachers Day

6 Teacher Stories Worth Watching

By
SK Panicker
September 5, 2026
UP Startup Policy 2026

UP Startup Policy 2026 Brings 7 Major Changes

By
NewsFacts Bureau
August 28, 2026
Meta Startup School in India

Meta’s New Startup School Targets India’s Next 200 Consumer Brands

By
NewsFacts Bureau
August 21, 2026
Vishwanath and Sons

Vishwanath and Sons Review: Suriya Shines in a Softer Avatar

By
SK Panicker
August 15, 2026

Latest Articles

Moderna sues Pfizer and BioNTech for violating the Covid19 vaccine patent

Moderna sues Pfizer and BioNTech for violating the Covid19 vaccine patent

By
TheNewsFacts
Intranasal Covid vaccine BBV154 is safe, regulators approvals awaited: Bharat Biotech

Intranasal Covid vaccine BBV154 is safe, regulators approvals awaited: Bharat Biotech

By
TheNewsFacts
Japan Approves COVAXIN booster dose for Travelers; reinforces the effectiveness of Universal Covid Vaccine

Japan Approves COVAXIN booster dose for Travelers; reinforces the effectiveness of Universal Covid Vaccine

By
TheNewsFacts
New Peer Review Proves COVAXIN Booster Dose Provides Multiple Benefits

New Peer Review Proves COVAXIN Booster Dose Provides Multiple Benefits

By
TheNewsFacts
COVAXIN Latest Peer Review Shows robust safety, immunogenicity in 2-18 years Old

COVAXIN is Safe, Highly Immunogenic in 2-18 Years Old – The Lancet Review

By
TheNewsFacts
Covaxin booster can defend new variants of concern: ICMR Study

COVAXIN booster can defend new variants of concern: ICMR Study

By
TheNewsFacts
Bharat Biotech consortium project for new variant proof Covid-19 Vaccine Gets CEPI Funding

Bharat Biotech consortium project for new variant proof Covid-19 Vaccine Gets CEPI Funding

By
TheNewsFacts
India Approves COVAXIN for Children 6 to 12 Years Age

India Approves COVAXIN for Children 6 to 12 Years Age

By
TheNewsFacts
1 2 3 4 … 8 9
thenewsfacts thenewsfacts

About US


TheNewsFacts: Brings you the interesting facts, news facts and updates from India an the world across politics, tech, entertainment, business, tending, and more. We deliver what you love to read.
Top Categories
  • Latest News
  • Trending News
  • Paris Olympics 2024
  • Sports
  • Entertainment
  • Business
  • Technology
Usefull Links
  • About The News Facts
  • Latest News
  • Privacy Policy
  • Editorial Policy
  • Disclaimer
  • Contact Us
Follow us
Facebook Twitter Instagram

© thenewsfacts. All Rights Reserved.

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?